Published in PLoS One on May 22, 2013
Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle (2014) 1.16
EPO-receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis. Physiol Rep (2014) 0.91
Genetic and epigenetic contributors to FSHD. Curr Opin Genet Dev (2015) 0.87
Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients. J Biol Chem (2013) 0.85
Emerging preclinical animal models for FSHD. Trends Mol Med (2015) 0.85
Direct interplay between two candidate genes in FSHD muscular dystrophy. Hum Mol Genet (2014) 0.80
A Human Pluripotent Stem Cell Model of Facioscapulohumeral Muscular Dystrophy-Affected Skeletal Muscles. Stem Cells Transl Med (2016) 0.79
DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis. J Cell Sci (2016) 0.78
Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD). PLoS One (2016) 0.77
Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation. PLoS One (2016) 0.77
Dux4 controls migration of mesenchymal stem cells through the Cxcr4-Sdf1 axis. Oncotarget (2016) 0.76
PARP1 Differentially Interacts with Promoter region of DUX4 Gene in FSHD Myoblasts. J Genet Syndr Gene Ther (2016) 0.75
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4. Hum Mol Genet (2016) 0.75
Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage. Histochem Cell Biol (2016) 0.75
Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature (1978) 11.49
MyoD or Myf-5 is required for the formation of skeletal muscle. Cell (1993) 7.14
MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science (1988) 6.78
Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature (1993) 6.75
Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul Disord (1991) 6.63
Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S A (2002) 5.18
Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet (1992) 5.12
Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer (1969) 4.99
A unifying genetic model for facioscapulohumeral muscular dystrophy. Science (2010) 4.87
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A (2007) 3.32
Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol Cell (2002) 3.29
Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene (1999) 3.00
Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet (2010) 2.95
Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet (2009) 2.90
Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet (2012) 2.82
An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J (2008) 2.74
Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood (2003) 2.65
RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet (2009) 2.51
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet (2003) 2.50
A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell (2012) 2.29
DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell (2011) 2.17
Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet (1990) 2.09
Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am J Hum Genet (2007) 2.06
DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol (2010) 1.89
Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 1.81
Premature myogenic differentiation and depletion of progenitor cells cause severe muscle hypotrophy in Delta1 mutants. Proc Natl Acad Sci U S A (2006) 1.76
Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res (1992) 1.72
Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci (2008) 1.68
Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain (1987) 1.66
Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord (2003) 1.56
Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet (2012) 1.48
DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp Neurol (2008) 1.48
The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One (2011) 1.45
On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy. Muscle Nerve Suppl (1995) 1.42
Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects. J Cell Mol Med (2008) 1.42
The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells. J Biol Chem (2000) 1.41
Testing the effects of FSHD candidate gene expression in vertebrate muscle development. Int J Clin Exp Pathol (2010) 1.34
BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells. Cell Death Differ (2010) 1.32
Restoration of p53 pathway by nutlin-3 induces cell cycle arrest and apoptosis in human rhabdomyosarcoma cells. Clin Cancer Res (2009) 1.31
P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med Pediatr Oncol (2000) 1.22
Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol (2001) 1.21
MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state. Genes Dev (2009) 1.18
Molecular responses of human muscle to eccentric exercise. J Appl Physiol (1985) (2003) 1.17
CD8(+) T cells in facioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J Clin Immunol (2010) 1.16
A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function. Eur J Hum Genet (2011) 1.14
Gene expression during normal and FSHD myogenesis. BMC Med Genomics (2011) 1.12
Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proc Natl Acad Sci U S A (2012) 1.11
WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J Bone Miner Res (2012) 1.08
Establishment of clonal myogenic cell lines from severely affected dystrophic muscles - CDK4 maintains the myogenic population. Skelet Muscle (2011) 1.05
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375. Br J Pharmacol (2005) 1.05
The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. Am J Hum Genet (2005) 1.03
Different molecular signatures in magnetic resonance imaging-staged facioscapulohumeral muscular dystrophy muscles. PLoS One (2012) 1.00
Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD. Am J Pathol (2012) 1.00
Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic Biol Med (2012) 0.99
Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns. PLoS One (2011) 0.99
Enhancement of vascular smooth muscle cell migration by urotensin II. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.96
Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration. Blood (2009) 0.93
Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells. Atherosclerosis (2005) 0.93
Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines. Br J Pharmacol (2004) 0.89
Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation. Mol Med Rep (2012) 0.89
The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma. J Recept Signal Transduct Res (2003) 0.85
Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes. Clin Sci (Lond) (2008) 0.83
Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro. Int J Mol Med (2006) 0.83
Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats. Can J Physiol Pharmacol (2004) 0.82
Desensitisation of native and recombinant human urotensin-II receptors. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.76
The draft genome of Ciona intestinalis: insights into chordate and vertebrate origins. Science (2002) 11.11
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A (2007) 3.32
The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord (2007) 2.85
An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J (2008) 2.74
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet (2003) 2.50
Sources of variability and effect of experimental approach on expression profiling data interpretation. BMC Bioinformatics (2002) 2.31
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain (2006) 2.22
Interactively optimizing signal-to-noise ratios in expression profiling: project-specific algorithm selection and detection p-value weighting in Affymetrix microarrays. Bioinformatics (2004) 1.98
DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol (2010) 1.89
Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum (2005) 1.67
Alterations in mRNA expression and protein products following spinal cord injury in humans. J Physiol (2007) 1.55
Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal (2012) 1.54
An analysis of anesthesia-controlled operating room time after propofol-based total intravenous anesthesia compared with desflurane anesthesia in ophthalmic surgery: a retrospective study. Anesth Analg (2014) 1.52
DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp Neurol (2008) 1.48
The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One (2011) 1.45
Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components. J Appl Physiol (1985) (2006) 1.45
Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci (2010) 1.29
Downregulation of myelination, energy, and translational genes in Menkes disease brain. Mol Genet Metab (2005) 1.24
Nuclear factor 90 mediates activation of the cellular antiviral expression cascade. AIDS Res Hum Retroviruses (2002) 1.16
DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation. PLoS One (2009) 1.12
Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis. J Proteome Res (2010) 1.09
Gene expression responses over 24 h to lengthening and shortening contractions in human muscle: major changes in CSRP3, MUSTN1, SIX1, and FBXO32. Physiol Genomics (2007) 1.09
DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med (2012) 1.06
Vibrio ruber sp. nov., a red, facultatively anaerobic, marine bacterium isolated from sea water. Int J Syst Evol Microbiol (2003) 1.05
Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum Genet (2011) 1.04
Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca2+ channels. J Cell Physiol (2008) 1.03
Xenopus Sox3 activates sox2 and geminin and indirectly represses Xvent2 expression to induce neural progenitor formation at the expense of non-neural ectodermal derivatives. Mech Dev (2008) 1.00
Synergistic contribution of CD14 and HLA loci in the susceptibility to Buerger disease. Hum Genet (2007) 1.00
A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. J Biomol Screen (2006) 0.99
Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: a cell model of heart ischemia-reperfusion injury and treatment. Free Radic Biol Med (2010) 0.99
Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction. Free Radic Biol Med (2012) 0.99
Elevated IgG titers to periodontal pathogens related to Buerger disease. Int J Cardiol (2007) 0.99
Forty-eight hours of unloading and 24 h of reloading lead to changes in global gene expression patterns related to ubiquitination and oxidative stress in humans. J Appl Physiol (1985) (2010) 0.98
Intracellular trafficking and dynamics of double homeodomain proteins. Biochemistry (2005) 0.95
Gene expression and muscle fiber function in a porcine ICU model. Physiol Genomics (2009) 0.95
Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis (2006) 0.93
Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities: a synthesis of systematic reviews. Int J Chron Obstruct Pulmon Dis (2012) 0.92
The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy. J Biol Chem (2011) 0.91
miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors. Orphanet J Rare Dis (2013) 0.91
IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse. BMC Musculoskelet Disord (2012) 0.91
Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice. Biol Open (2012) 0.90
Mechanisms underlying the sparing of masticatory versus limb muscle function in an experimental critical illness model. Physiol Genomics (2011) 0.89
Relationship between metabolic syndrome and diagnoses of periodontal diseases among participants in a large Taiwanese cohort. J Clin Periodontol (2013) 0.89
Effect of high glucose on secreted proteome in cultured retinal pigmented epithelium cells: its possible relevance to clinical diabetic retinopathy. J Proteomics (2012) 0.88
Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2. Am J Physiol Cell Physiol (2005) 0.87
Sorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. J Cancer Res Clin Oncol (2014) 0.87
Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma. J Pharm Biomed Anal (2012) 0.87
The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage. Arthritis Rheum (2011) 0.87
Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis. J Proteomics (2012) 0.86
Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients. J Biol Chem (2013) 0.85
A saturation screen for cis-acting regulatory DNA in the Hox genes of Ciona intestinalis. Proc Natl Acad Sci U S A (2005) 0.85
STAT1 activation by venous malformations mutant Tie2-R849W antagonizes VEGF-A-mediated angiogenic response partly via reduced bFGF production. Angiogenesis (2012) 0.84
Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells. J Proteomics (2012) 0.84
A human proteome microarray identifies that the heterogeneous nuclear ribonucleoprotein K (hnRNP K) recognizes the 5' terminal sequence of the hepatitis C virus RNA. Mol Cell Proteomics (2013) 0.83
Impaired autophagy, chaperone expression, and protein synthesis in response to critical illness interventions in porcine skeletal muscle. Physiol Genomics (2013) 0.83
Dopaminergic Therapy Modulates Cortical Perfusion in Parkinson Disease With and Without Dementia According to Arterial Spin Labeled Perfusion Magnetic Resonance Imaging. Medicine (Baltimore) (2016) 0.83
Gene expression profiling of gastrocnemius of "minimuscle" mice. Physiol Genomics (2013) 0.83
Hyaluronic acid-dependent protection against UVB-damaged human corneal cells. Environ Mol Mutagen (2013) 0.82
Proteomic identification of plasma biomarkers in uterine leiomyoma. Mol Biosyst (2011) 0.82
Hyaluronic acid-dependent protection against alkali-burned human corneal cells. Electrophoresis (2013) 0.81
Plasma proteomic analysis of the critical limb ischemia markers in diabetic patients with hemodialysis. Mol Biosyst (2011) 0.81
Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: implications for the diagnosis of coronavirus infection. J Virol Methods (2012) 0.81
Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells. J Proteomics (2012) 0.80
Conditional expression of TGF-β1 in skeletal muscles causes endomysial fibrosis and myofibers atrophy. PLoS One (2013) 0.80
Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: Role of glucose-induced ROS. J Proteomics (2012) 0.80
Acute iatrogenic Budd-Chiari syndrome following hepatectomy for hepatolithiasis: a report of two cases. World J Gastroenterol (2013) 0.80
The effects of injectable calcium silicate-based composites with the Chinese herb on an osteogenic accelerator in vitro. Biomed Mater (2015) 0.79
The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas. Histopathology (2009) 0.79
Gene selection for multiclass prediction by weighted Fisher criterion. EURASIP J Bioinform Syst Biol (2007) 0.79
Composite nano-titanium oxide-chitosan artificial skin exhibits strong wound-healing effect-an approach with anti-inflammatory and bactericidal kinetics. Macromol Biosci (2008) 0.79
The synergistic effects of Chinese herb and injectable calcium silicate/β-tricalcium phosphate composite on an osteogenic accelerator in vitro. J Mater Sci Mater Med (2015) 0.79
FSHD myotubes with different phenotypes exhibit distinct proteomes. PLoS One (2012) 0.78
Redox-proteomic analysis of doxorubicin-induced altered thiol activity in cardiomyocytes. Mol Biosyst (2013) 0.78
Expression of the helicase-like transcription factor and its variants during carcinogenesis of the uterine cervix: implications for tumour progression. Histopathology (2011) 0.78
Beauvericin activates Ca2+-activated Cl- currents and induces cell deaths in Xenopus oocytes via influx of extracellular Ca2+. Chem Res Toxicol (2005) 0.78
Early expression of the Helicase-Like Transcription Factor (HLTF/SMARCA3) in an experimental model of estrogen-induced renal carcinogenesis. Mol Cancer (2006) 0.77
High glucose-induced proteome alterations in retinal pigmented epithelium cells and its possible relevance to diabetic retinopathy. Mol Biosyst (2012) 0.77
Proteome differences between male and female fetal cells in amniotic fluid. OMICS (2012) 0.77
Effects of corticosteroids in the development of limb muscle weakness in a porcine intensive care unit model. Physiol Genomics (2013) 0.77
Selective enhancement of tonic inhibition by increasing ambient GABA is insufficient to suppress excitotoxicity in hippocampal neurons. Biochem Biophys Res Commun (2005) 0.77
Synthesis, bifunctionalization, and remarkable adsorption performance of benzene-bridged periodic mesoporous organosilicas functionalized with high loadings of carboxylic acids. Chemistry (2013) 0.77
Development and production of an oligonucleotide MuscleChip: use for validation of ambiguous ESTs. BMC Bioinformatics (2002) 0.77
Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Arch (2008) 0.76
Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma. Mol Biosyst (2012) 0.76
High-performance anion-exchange chromatography coupled with diode array detection for the determination of dencichine in Panax notoginseng and related species. J Sep Sci (2013) 0.76
Role of sepsis in the development of limb muscle weakness in a porcine intensive care unit model. Physiol Genomics (2012) 0.76
Can overconfidence be debiased by low-probability/high-consequence events? Risk Anal (2010) 0.76
Survey of Asian patients with hepatitis B infection: limited knowledge of transmission and screening of family members. J Immigr Minor Health (2015) 0.75
Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers. BMC Cancer (2014) 0.75
Genetic medicine and the muscular dystrophies: triumphs and tribulations. Dev Med Child Neurol (2002) 0.75
Proteomic analysis of rhein-induced cyt: ER stress mediates cell death in breast cancer cells. Mol Biosyst (2014) 0.75
Redox-proteomic analysis of doxorubicin resistance-induced altered thiol activity in uterine carcinoma. J Pharm Biomed Anal (2013) 0.75
Reliability and Validity of Cervical Range of Motion and Muscle Strength Testing. J Strength Cond Res (2016) 0.75
Measurement of translesion synthesis by fluorescent capillary electrophoresis: 7,8-dihydro-8-oxodeoxyguanosine bypass modulation by natural products. Anal Biochem (2013) 0.75
On-chip microelectrophoresis for the study of in vitro nonhomologous end-joining DNA double-strand break repair. Anal Biochem (2012) 0.75
Identifying emerging trends for implementing learning technology in special education: a state-of-the-art review of selected articles published in 2008-2012. Res Dev Disabil (2013) 0.75
The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor? Cell Mol Life Sci (2016) 0.75
Antibody Profiling of Bipolar Disorder Using Escherichia coli Proteome Microarrays. Mol Cell Proteomics (2015) 0.75